A Study Comparison of Clinical Outcome After Different Rate of Infusion in Caudal Epidural Steroid Injection

NCT ID: NCT02939482

Last Updated: 2019-06-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

112 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-10-01

Study Completion Date

2019-01-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the effects of different rates of Caudal Epidural Steroid Injection (CESI) on clinical outcomes of the patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spinal Stenosis Lumbosacral Spondylosis Radiculopathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1: 40 ml/min

Triamcinolone acetonide (80 mg)/2 ml and normal saline solution 18 ml infusion in 0.5 min

Group Type ACTIVE_COMPARATOR

Triamcinolone Acetonide and normal saline solution

Intervention Type DRUG

80 mg/2 ml Triamcinolone Acetonide and 18 ml normal saline solution

Group 2: 20 ml/min

Triamcinolone acetonide (80 mg)/2 ml and normal saline solution 18 ml infusion in 1 min

Group Type EXPERIMENTAL

Triamcinolone Acetonide and normal saline solution

Intervention Type DRUG

80 mg/2 ml Triamcinolone Acetonide and 18 ml normal saline solution

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Triamcinolone Acetonide and normal saline solution

80 mg/2 ml Triamcinolone Acetonide and 18 ml normal saline solution

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* lumbosacral spinal stenosis with radiculopathy
* no improvement after conservative treatment for 6 weeks

Exclusion Criteria

* previous CESI or spinal surgery
* skin infection at injection site
* uncontrolled diabetes mellitus
* abnormal coagulogram
* vertebral fracture
* previous history of allergy to steroid or anesthetic agent
Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Navamindradhiraj University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Satit Thiengwittayaporn

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Satit Thiengwittayaporn, M.D.

Role: PRINCIPAL_INVESTIGATOR

Navamindradhiraj University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Navamindradhiraj University

Dusit, Bangkok, Thailand

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Thailand

References

Explore related publications, articles, or registry entries linked to this study.

Watts RW, Silagy CA. A meta-analysis on the efficacy of epidural corticosteroids in the treatment of sciatica. Anaesth Intensive Care. 1995 Oct;23(5):564-9. doi: 10.1177/0310057X9502300506.

Reference Type RESULT
PMID: 8787255 (View on PubMed)

Botwin KP, Gruber RD, Bouchlas CG, Torres-Ramos FM, Sanelli JT, Freeman ED, Slaten WK, Rao S. Fluoroscopically guided lumbar transformational epidural steroid injections in degenerative lumbar stenosis: an outcome study. Am J Phys Med Rehabil. 2002 Dec;81(12):898-905. doi: 10.1097/00002060-200212000-00003.

Reference Type RESULT
PMID: 12447088 (View on PubMed)

Kraiwattanapong C, Wechmongkolgorn S, Chatriyanuyok B, Woratanarat P, Udomsubpayakul U, Chanplakorn P, Keorochana G, Wajanavisit W. Outcomes of fluoroscopically guided lumbar transforaminal epidural steroid injections in degenerative lumbar spondylolisthesis patients. Asian Spine J. 2014 Apr;8(2):119-28. doi: 10.4184/asj.2014.8.2.119. Epub 2014 Apr 8.

Reference Type RESULT
PMID: 24761192 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

COA 74/2559

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.